Posted by SLS on May 8, 2006, at 7:45:41
In reply to Re: Statistical question on SSRIs, posted by bassman on May 8, 2006, at 6:23:11
Reboxetine was denied approval by the FDA several years ago because the clinical investigations performed in the US were failed studies. Neither reboxetine nor fluoxetine demonstrated superiority over placebo.
My impression over these last five years is that reboxetine is not as effective as desipramine as a NARI. A few people have responded favorably to it, but it seems that many more have not.
My personal experience with reboxetine was that it made my depression significantly worse and produced anxiety.
I did not like atomoxetine. It produced fatigue and did not help much with depression.
I am very treatment-resistant, so my reactions to these drugs may not be typical.
- Scott
poster:SLS
thread:640557
URL: http://www.dr-bob.org/babble/20060504/msgs/641249.html